Post-transfusion hepatitis after open-heart surgery in Finland--a prospective study. 1991

F Ebeling, and R Naukkarinen, and R Hanhela, and J Jalonen, and L Kaukinen, and M Salmenperä, and M Suistomaa, and J Leikola
Finnish Red Cross Blood Transfusion Service, Helsinki, Finland.

A countrywide prospective study on open-heart surgery patients was performed between 1987 and 1989 to determine the prevalence and nature of post-transfusion hepatitis in Finland. Altogether 685 coronary by-pass operation patients, who received on average 12.3 units of blood products, were postoperatively followed for 6 months. Ten blood samples were drawn from each patient. Hepatitis was diagnosed when the alanine aminotransferase values exceeded the upper normal value 2.5 times in one sample and twice in another, and non-viral causes could reasonably be excluded. Eleven hepatitis cases (1.6%) were recorded with a mean incubation period of 8.4 weeks; all represented the non-A, non-B type. The majority had mild symptoms or were asymptomatic but two became icteric. Six patients (55%) had abnormal alanine aminotransferase values for at least 6 months, which indicates possible chronicity. These 685 open-heart surgery patients received a total of 8,436 units of blood products; thus the rate of NANBH cases per 1000 units was as low as 1.3. This is less than recently reported in six other prospective studies.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D005260 Female Females
D005387 Finland A country in northern Europe, bordering the Baltic Sea, Gulf of Bothnia, and Gulf of Finland, between Sweden and Russia. The capital is Helsinki. Aland Islands,Åland Islands
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006509 Hepatitis B INFLAMMATION of the LIVER in humans caused by a member of the ORTHOHEPADNAVIRUS genus, HEPATITIS B VIRUS. It is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact. Hepatitis B Virus Infection
D006510 Hepatitis B Antibodies Antibodies to the HEPATITIS B ANTIGENS, including antibodies to the surface (Australia) and core of the Dane particle and those to the "e" antigens. Anti-Australia Antigens,Anti-HBAg,Anti-Hepatitis B Antigens,Anti HBAg,Hepatitis B Virus Antibodies,Anti Australia Antigens,Anti Hepatitis B Antigens,Antibodies, Hepatitis B,Antigens, Anti-Australia,Antigens, Anti-Hepatitis B,B Antibodies, Hepatitis,B Antigens, Anti-Hepatitis,HBAg, Anti
D006526 Hepatitis C INFLAMMATION of the LIVER in humans caused by HEPATITIS C VIRUS, a single-stranded RNA virus. Its incubation period is 30-90 days. Hepatitis C is transmitted primarily by contaminated blood parenterally and is often associated with transfusion and intravenous drug abuse. However, in a significant number of cases, the source of hepatitis C infection is unknown. Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted,Parenterally-Transmitted Non-A, Non-B Hepatitis,PT-NANBH,Parenterally Transmitted Non A, Non B Hepatitis
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

F Ebeling, and R Naukkarinen, and R Hanhela, and J Jalonen, and L Kaukinen, and M Salmenperä, and M Suistomaa, and J Leikola
February 1993, Journal of medical virology,
F Ebeling, and R Naukkarinen, and R Hanhela, and J Jalonen, and L Kaukinen, and M Salmenperä, and M Suistomaa, and J Leikola
November 1982, Scandinavian journal of clinical and laboratory investigation,
F Ebeling, and R Naukkarinen, and R Hanhela, and J Jalonen, and L Kaukinen, and M Salmenperä, and M Suistomaa, and J Leikola
February 1985, Gematologiia i transfuziologiia,
F Ebeling, and R Naukkarinen, and R Hanhela, and J Jalonen, and L Kaukinen, and M Salmenperä, and M Suistomaa, and J Leikola
November 1983, British medical journal (Clinical research ed.),
F Ebeling, and R Naukkarinen, and R Hanhela, and J Jalonen, and L Kaukinen, and M Salmenperä, and M Suistomaa, and J Leikola
March 1983, Die Medizinische Welt,
F Ebeling, and R Naukkarinen, and R Hanhela, and J Jalonen, and L Kaukinen, and M Salmenperä, and M Suistomaa, and J Leikola
November 1986, The Indian journal of medical research,
F Ebeling, and R Naukkarinen, and R Hanhela, and J Jalonen, and L Kaukinen, and M Salmenperä, and M Suistomaa, and J Leikola
November 1963, Archives of surgery (Chicago, Ill. : 1960),
F Ebeling, and R Naukkarinen, and R Hanhela, and J Jalonen, and L Kaukinen, and M Salmenperä, and M Suistomaa, and J Leikola
January 1993, Duodecim; laaketieteellinen aikakauskirja,
F Ebeling, and R Naukkarinen, and R Hanhela, and J Jalonen, and L Kaukinen, and M Salmenperä, and M Suistomaa, and J Leikola
November 1986, Lancet (London, England),
F Ebeling, and R Naukkarinen, and R Hanhela, and J Jalonen, and L Kaukinen, and M Salmenperä, and M Suistomaa, and J Leikola
January 1984, Thorax,
Copied contents to your clipboard!